nicergoline has been researched along with Cognition Disorders in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Garg, A; Saletu, B; Shoeb, A | 1 |
| Battaglia, A; Battaglia, G; Bosco, P; Calafiore, M; Canonico, PL; Caraci, F; Chisari, M; Copani, A; Frasca, G; Nicoletti, F; Sortino, MA | 1 |
| Fioravanti, M; Flicker, L | 1 |
| Aloe, L; Battaglia, A; Calza', L; Carfagna, N; Giardino, L; Giuliani, A | 1 |
| Arnetoli, G; Battaglia, A; Grignani, A; Paganini, M; Sacchetti, G; Versari, A; Zappoli, R | 1 |
2 review(s) available for nicergoline and Cognition Disorders
| Article | Year |
|---|---|
Safety of nicergoline as an agent for management of cognitive function disorders.
Topics: Cognition Disorders; Drug Interactions; Ergotism; Fibrosis; Humans; Nicergoline; Nootropic Agents | 2014 |
Efficacy of nicergoline in dementia and other age associated forms of cognitive impairment.
Topics: Cognition Disorders; Dementia; Humans; Nicergoline; Nootropic Agents; Randomized Controlled Trials as Topic | 2001 |
1 trial(s) available for nicergoline and Cognition Disorders
| Article | Year |
|---|---|
Contingent negative variation and reaction time in patients with presenile idiopathic cognitive decline and presenile Alzheimer-type dementia. Preliminary report on long-term nicergoline treatment.
Topics: Alzheimer Disease; Cognition Disorders; Contingent Negative Variation; Double-Blind Method; Electroencephalography; Electrophysiology; Ergolines; Female; Humans; Male; Middle Aged; Nicergoline; Reaction Time | 1987 |
2 other study(ies) available for nicergoline and Cognition Disorders
| Article | Year |
|---|---|
Nicergoline, a drug used for age-dependent cognitive impairment, protects cultured neurons against beta-amyloid toxicity.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Apoptosis; Astrocytes; bcl-2-Associated X Protein; Cell Communication; Cells, Cultured; Cerebral Cortex; Coculture Techniques; Cognition Disorders; Memory Disorders; Nerve Growth Factors; Neurons; Neuroprotective Agents; Nicergoline; Peptide Fragments; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley | 2005 |
Neuroprotection and aging of the cholinergic system: a role for the ergoline derivative nicergoline (Sermion).
Topics: Aging; Animals; Choline O-Acetyltransferase; Cholinergic Fibers; Cognition Disorders; Colchicine; Down-Regulation; Male; Nerve Degeneration; Nerve Growth Factor; Neuroprotective Agents; Nicergoline; Nitric Oxide Synthase; Nootropic Agents; Rats; RNA, Messenger; Septal Nuclei | 2002 |